technologia: Elizabeth Holmes

Evidence: 47 • authority: 92

Lessons from Theranos - Restructuring Biomedical Innovation.. After raising more than $700 million, Elizabeth Holmes, the founder and chief executive officer of a healthcare startup once valued at $10 billion, was found guilty on four charges of defrauding investors. Founded in 2003, Theranos Inc. was a privately held corporation that aimed to disrupt the diagnostics industry with rapid, direct-to-consumer laboratory testing using only "a drop of blood" and the company's patented Nanotainer technology. By exploiting gaps in regulatory policy, Theranos brought its panel of laboratory tests to patients without pre-market review or validation from peer-reviewed scientific research. Investigati…

Evidence: 42 • authority: 92

The meteoric rise and dramatic fall of Theranos: lessons learned for the diagnostic industry.. In this piece we discuss and reflect on the conclusion of the Theranos saga in the light of its fraud conviction. Theranos (founded in 2003 by Elizabeth Holmes) was supposed to disrupt the diagnostic testing industry by developing technology which could perform dozens of tests using a tiny amount of blood from a finger-prick. As a result, Ms. Holmes rose to fame, becoming the world's youngest female self-made billionaire and was plastered across magazine covers. However, in 2014, Theranos began to fall apart following increasingly damaging revelations regarding its lack of expertise, technology, f…

Evidence: 100 • authority: 72

Elizabeth Anne Holmes (born February 3, 1984) is an American businesswoman convicted of fraud in connection with her health technology company Theranos. Holmes founded Theranos in 2003, and its valuation soared in the early 2010s after it claimed to have revolutionized blood testing by developing methods that needed only very small volumes of blood, such as from a fingerprick. In 2015, Forbes named Holmes the youngest and wealthiest self-made female billionaire in the United States on the basis of a $9-billion valuation of Theranos. In the following year, as accusations of fraud about Theranos's claims began to surface, Forbes revised its estimate of Holmes's net worth to zero. The decline…

Evidence: 58 • authority: 72

Theranos Inc. () was an American privately held corporation that was touted as a breakthrough health technology company. Founded in 2003 by then–19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $9 billion valuation at its peak in 2013 and 2014. The company falsely claimed that it had devised blood tests that could be performed rapidly and accurately, while requiring very small amounts of blood, all using compact automated devices that the company had developed. A turning point came in 2015, when medical research professor John Ioannidis, and later, professor of clinical biochemistry Eleftherios Diamandis, a…

Evidence: 38 • authority: 72

Ramesh "Sunny" Balwani (born June 13, 1965) is a Pakistani businessman who was the former president and chief operating officer of Theranos, which was a privately held health technology company founded by his then-girlfriend Elizabeth Holmes. He and Holmes fraudulently represented that they had devised a revolutionary blood test that required only small amounts of blood, such as from a fingerstick. Both Balwani and Holmes were convicted of fraud. The consequences of the fraud led to the collapse of Theranos and the loss of billions of dollars to investors. Starting in 2015, Theranos came under criticism in the media due to its questionable claims and practices. The company was eventually li…

Evidence: 36 • authority: 72

Haemanthus (sometimes stylized as Hæmanthus) is an American blood testing startup founded by Billy Evans, the romantic partner of Elizabeth Holmes. Holmes founded Theranos in 2003, which purported to have developed similar blood tests. However, the claims by Theranos were false and the company and people related to it were charged with fraud, leading to the company's disestablishment and Holmes being sentenced to 11 years in prison. Haemanthus uses Raman Spectroscopy, a technique that has been used to diagnose ALS and a few types of cancer.

Evidence: 27 • authority: 88

Elizabeth Holmes and Theranos: A play on more than just ethical failures. Elizabeth Holmes promised a revolution in blood testing protocols by building innovative technology and process efficiencies in an industry ripe for disruption. Along with Ramesh Balwani, she recruited investors under the guise of these promises and raked in millions of dollars in addition to lucrative private partnerships to bring her vision for the company, Theranos, to fruition. Behind the scenes, the enforcement of strict codes of secrecy left many in the scientific community skeptical of such claims as the company chose to abandon standard procedures including peer review. Additionally, the company initially empl…

Evidence: 22 • authority: 88

Downfall, Catharsis and Re-gendering: Entrepreneurial glorification and the case of Theranos’ Elizabeth Holmes. Gender shapes collective narratives of entrepreneurial ascent and failure in multiple and often contradictory ways, but how this happens remains under-researched. We argue that catharsis – a concept rarely used in organization studies – helps shed light on how female startup founders can be targeted and responsibilized in the post-failure descent, even after being glorified as exceptional and lucrative investment objects during the ascent of their venture. We illustrate our claims via a highly mediatized case: Elizabeth Holmes at Theranos. While extreme, the significant public att…

Evidence: 22 • authority: 88

Bad Witches: Gender and the Downfall of Elizabeth Holmes of Theranos and Disney’s Maleficent. Female villains, both fictional and real, are subject to unconscious gender bias when part of their iniquity involves the disruption of male authority. Disney’s most popular animated villain, Maleficent, from Sleeping Beauty (1959) and Elizabeth Holmes of the now-disgraced blood testing startup, Theranos, reveled in their power, deviating from idealized feminine propriety. An analysis of scenes featuring Maleficent, the “mistress of all evil”, and coverage of Elizabeth Holmes, once the first self-made female billionaire, illustrate how powerful women with hubris are censured beyond their misdeeds.…

Evidence: 22 • authority: 92

Sorry you asked? <i>Mayo, Myriad</i>, and the battles over patent-eligibility.. Genetic testing for inherited cancer risk changed dramatically when the US Supreme Court handed down unanimous rulings in Mayo v. Prometheus (2012) and Myriad v. Association for Molecular Pathology (2013). Those decisions struck down claims to methods based on 'laws of nature' ( Mayo ) and DNA molecules corresponding to sequences found in nature ( Myriad ). Senators Thom Tillis (R-NC) and Christopher Coons (D-DE) introduced legislation that would abrogate those decisions and specify narrow statutory exclusions to patent-eligibility in §101 of the US Patent Act. What would be the consequences of doing…